Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0016382 (
flushing
)
6,387
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neurokinin B
(
NKB
) is a hypothalamic neuropeptide binding preferentially to the neurokinin 3 receptor. Expression of the gene encoding
NKB
is elevated in postmenopausal women. Furthermore, rodent studies suggest that
NKB
signalling may mediate menopausal hot flushes. However, the effects of
NKB
administration on hot flushes have not been investigated in humans. To address this, we performed a randomised, double-blinded, placebo-controlled, 2-way cross-over study. Ten healthy women were admitted to a temperature and humidity-controlled research unit. Participants received 30 minute intravenous infusions of
NKB
and vehicle in random order. Symptoms, heart rate, blood pressure, sweating and skin temperature were compared between
NKB
and vehicle in a double-blinded manner. Eight of ten participants experienced
flushing
during
NKB
infusion with none experiencing
flushing
during vehicle infusion (P = 0.0007). Significant elevations in heart rate (P = 0.0106 vs. pre-symptoms), and skin temperature measured using skin probe (P = 0.0258 vs. pre-symptoms) and thermal imaging (P = 0.0491 vs. pre-symptoms) characteristic of menopausal
flushing
were observed during hot flush episodes. Our findings provide evidence that
NKB
administration can cause hot flushes in women. Further studies are required to determine if pharmacological blockade of
NKB
signalling could inhibit hot flushes during the menopause and during treatment for sex-steroid dependent cancers.
...
PMID:Neurokinin B administration induces hot flushes in women. 2568 60